Skip to content

Clinical trials

Completed Lymphoma, T-Cell, Peripheral trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Status: Completed Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20122
20151
20181
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acrotech Biopharma Inc.1
Associazione Angela Serra per la ricerca sul cancro1
AstraZeneca1
Celgene1
Kyowa Kirin Co., Ltd.1
Millennium Pharmaceuticals, Inc.1
Seagen, a wholly owned subsidiary of Pfizer1
SecuraBio1
Spectrum Pharmaceuticals, Inc1
University Hospital Southampton NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral11
Lymphoma, T-Cell3
Lymphoma2
Recurrence2
Burkitt Lymphoma1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell, Marginal Zone1
Lymphoma, Follicular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.